{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:11:29Z","timestamp":1790730689502,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00535-017-1372-8","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T05:51:54Z","timestamp":1500961914000},"page":"438-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Yuya","family":"Seko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Taketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichiro","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihisa","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohichiroh","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Kamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Nishioji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiroh","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,25]]},"reference":[{"key":"1372_CR1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005\u201323.","journal-title":"Hepatology"},{"issue":"4","key":"1372_CR2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00535-015-1050-7","volume":"50","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Hashimoto E, Ikejima K, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. J Gastroenterol. 2015;50(4):364\u201377.","journal-title":"J Gastroenterol"},{"issue":"3","key":"1372_CR3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00535-014-0973-8","volume":"50","author":"R Tateishi","year":"2015","unstructured":"Tateishi R, Okanoue T, Fujiwara N, et al. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol. 2015;50(3):350\u201360.","journal-title":"J Gastroenterol"},{"issue":"2","key":"1372_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver Fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389\u201397.","journal-title":"Gastroenterology"},{"issue":"7","key":"1372_CR5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/hepr.12407","volume":"45","author":"Y Seko","year":"2015","unstructured":"Seko Y, Sumida Y, Tanaka S, et al. Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease. Hepatol Res. 2015;45(7):728\u201338.","journal-title":"Hepatol Res"},{"issue":"4","key":"1372_CR6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917\u201323.","journal-title":"Hepatology"},{"issue":"11","key":"1372_CR7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","volume":"7","author":"NI Hossain","year":"2009","unstructured":"Hossain NI, Afendy A, Stepanova M. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(11):1224\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"1372_CR8","first-page":"S11","volume":"40","author":"I Liou","year":"2006","unstructured":"Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol. 2006;40(Suppl 1):S11\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1372_CR9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.mcna.2007.06.001","volume":"91","author":"MF Abdelmalek","year":"2007","unstructured":"Abdelmalek MF, Diehl AM. Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin N Am. 2007;91(6):1125\u201349.","journal-title":"Med Clin N Am"},{"issue":"11","key":"1372_CR10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00535-013-0911-1","volume":"49","author":"T Nakahara","year":"2014","unstructured":"Nakahara T, Hyogo H, Yoneda M, et al. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol. 2014;49(11):1477\u201384.","journal-title":"J Gastroenterol"},{"key":"1372_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gastrohep.2011.08.002","volume":"35","author":"R Hernaez","year":"2012","unstructured":"Hernaez R. Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. Gastroenterol Hepatol. 2012;35:32\u201341.","journal-title":"Gastroenterol Hepatol"},{"key":"1372_CR12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1053\/j.gastro.2010.07.057","volume":"139","author":"N Chalasani","year":"2010","unstructured":"Chalasani N, Guo X, Loomba R, et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology. 2010;139:1567\u201376 (1576.e1\u20136).","journal-title":"Gastroenterology"},{"key":"1372_CR13","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","volume":"7","author":"EK Speliotes","year":"2011","unstructured":"Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7:e1001324.","journal-title":"PLoS Genet"},{"key":"1372_CR14","doi-asserted-by":"crossref","first-page":"e38322","DOI":"10.1371\/journal.pone.0038322","volume":"7","author":"T Kawaguchi","year":"2012","unstructured":"Kawaguchi T, Sumida Y, Umemura A, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One. 2012;7:e38322.","journal-title":"PLoS One"},{"key":"1372_CR15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajhg.2008.09.012","volume":"83","author":"X Yuan","year":"2008","unstructured":"Yuan X, Waterworth D, Perry JRB, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet. 2008;83:520\u20138.","journal-title":"Am J Hum Genet"},{"key":"1372_CR16","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","volume":"53","author":"S Sookoian","year":"2011","unstructured":"Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 2011;53:1883\u201394.","journal-title":"Hepatology"},{"key":"1372_CR17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2012.09.036","volume":"58","author":"E Guyot","year":"2013","unstructured":"Guyot E, Sutton A, Rufat P, et al. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction inpatients with cirrhosis. J Hepatol. 2013;58:312\u20138.","journal-title":"J Hepatol"},{"key":"1372_CR18","doi-asserted-by":"crossref","first-page":"e27087","DOI":"10.1371\/journal.pone.0027087","volume":"6","author":"HD Nischalke","year":"2011","unstructured":"Nischalke HD, Berger C, Luda C, et al. The PNPLA3 rs738409 148\u00a0M\/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS One. 2011;6:e27087.","journal-title":"PLoS One"},{"key":"1372_CR19","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/hep.25518","volume":"55","author":"E Trepo","year":"2012","unstructured":"Trepo E, Guyot E, Ganne-Carrie N, et al. PNPLA3 (rs738409 C\u00a0>\u00a0G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis. Hepatology. 2012;55:1307\u20138.","journal-title":"Hepatology"},{"issue":"6","key":"1372_CR20","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/hep.26767","volume":"59","author":"E Trepo","year":"2014","unstructured":"Trepo E, Nahon P, Bontempi G, et al. Association between the PNPLA3 (rs738409 C\u00a0>\u00a0G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology. 2014;59(6):2170\u20137.","journal-title":"Hepatology"},{"key":"1372_CR21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","volume":"53","author":"L Valenti","year":"2011","unstructured":"Valenti L, Rumi M, Galmozzi E, et al. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology. 2011;53:791\u20139.","journal-title":"Hepatology"},{"key":"1372_CR22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2011.02534.x","volume":"31","author":"E Falleti","year":"2011","unstructured":"Falleti E, Fabris C, Cmet S, et al. PNPLA3 rs738409C\/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int. 2011;31:1137\u201343.","journal-title":"Liver Int"},{"key":"1372_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","volume":"61","author":"YL Liu","year":"2014","unstructured":"Liu YL, Patman GL, Leathart JB, et al. Carriage of the PNPLA3 rs738409 C\u00a0<\u00a0G polymorphism confers an increased risk of nonalcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol. 2014;61:75\u201381.","journal-title":"J Hepatol"},{"issue":"4","key":"1372_CR24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00535-015-1116-6","volume":"51","author":"M Ueyama","year":"2016","unstructured":"Ueyama M, Nishida N, Korenaga M, et al. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. J Gastroenterol. 2016;51(4):370\u20139.","journal-title":"J Gastroenterol"},{"issue":"3","key":"1372_CR25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00535-012-0647-3","volume":"48","author":"Y Takeuchi","year":"2013","unstructured":"Takeuchi Y, Ikeda F, Moritou Y, et al. The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. J Gastroenterol. 2013;48(3):405\u201312.","journal-title":"J Gastroenterol"},{"key":"1372_CR26","doi-asserted-by":"publisher","unstructured":"Seko Y, Sumida Y, Tanaka S, et al. Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: association between PNPLA3 genotype and hepatocarcinogenesis\/fibrosis progression. Hepatol Res. 2016. doi:\n                        10.1111\/hepr.12840\n                        \n                    .","DOI":"10.1111\/hepr.12840"},{"key":"1372_CR27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/db13-0774","volume":"63","author":"J Hyysalo","year":"2014","unstructured":"Hyysalo J, Gopalacharyulu P, Bian H, et al. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity. Diabetes. 2014;63:312\u201322.","journal-title":"Diabetes"},{"key":"1372_CR28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1194\/jlr.M046607","volume":"55","author":"H Ruhanen","year":"2014","unstructured":"Ruhanen H, Perttil\u00e4 J, H\u00f6ltt\u00e4-Vuori M, et al. PNPLA3 mediates hepatocyte triacylglycerol remodeling. J Lipid Res. 2014;55:739\u201346.","journal-title":"J Lipid Res"},{"key":"1372_CR29","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","volume":"57","author":"C Pirazzi","year":"2012","unstructured":"Pirazzi C, Adiels M, Burza MA, et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148\u00a0M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J Hepatol. 2012;57:1276\u201382.","journal-title":"J Hepatol"},{"key":"1372_CR30","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","volume":"23","author":"C Pirazzi","year":"2014","unstructured":"Pirazzi C, Valenti L, Motta BM, et al. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. Hum Mol Genet. 2014;23:4077\u201385.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1372_CR31","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","volume":"51","author":"L Valenti","year":"2010","unstructured":"Valenti L, Al-Serri A, Daly AK, et al. Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51(4):1209\u201317.","journal-title":"Hepatology"},{"issue":"6","key":"1372_CR32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2017.01.041","volume":"152","author":"K Matsuura","year":"2017","unstructured":"Matsuura K, Sawai H, Ikeo K, et al. Japanese genome-wide association study group for viral hepatitis. genome-wide association study identifies TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus infection. Gastroenterology. 2017;152(6):1383\u201394.","journal-title":"Gastroenterology"},{"issue":"10","key":"1372_CR33","doi-asserted-by":"publisher","first-page":"e0140427","DOI":"10.1371\/journal.pone.0140427","volume":"10","author":"K Nishioji","year":"2015","unstructured":"Nishioji K, Mochizuki N, Kobayashi M, et al. The impact of PNPLA3 rs738409 genetic polymorphism and weight gain\u00a0\u226510\u00a0kg after age 20 on non-alcoholic fatty liver disease in non-obese Japanese individuals. PLoS One. 2015;10(10):e0140427. doi:\n                        10.1371\/journal.pone.0140427\n                        \n                    .","journal-title":"PLoS One"},{"issue":"1","key":"1372_CR34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32\u20136.","journal-title":"Hepatology"},{"key":"1372_CR35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive sys-tem that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u201354.","journal-title":"Hepatology"},{"key":"1372_CR36","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwandet-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57:1441\u20137.","journal-title":"Gut"},{"key":"1372_CR37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2105\/AJPH.49.10.1349","volume":"49","author":"TR Dawber","year":"1959","unstructured":"Dawber TR, Kannel WB, Revotskie N, et al. Some factors associated with the development of coronary heart disease: six years\u2019 follow-up experience in the Framingham study. Am J Public Health Nations Health. 1959;49:1349\u201356.","journal-title":"Am J Public Health Nations Health"},{"issue":"9","key":"1372_CR38","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.5551\/jat.Er19356","volume":"23","author":"K Nishimura","year":"2016","unstructured":"Nishimura K, Okamura T, Watanabe M, et al. Predicting coronary heart disease using risk factor categories for a Japanese Urban population, and comparison with the Framingham risk score: the Suita study. J Atheroscler Thromb. 2016;23(9):1138\u20139.","journal-title":"J Atheroscler Thromb"},{"key":"1372_CR39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-014-0948-9","volume":"50","author":"K Nishioji","year":"2015","unstructured":"Nishioji K, Sumida Y, Kamaguchi M, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011\u20132012. J Gastroenterol. 2015;50:95\u2013108.","journal-title":"J Gastroenterol"},{"key":"1372_CR40","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","volume":"38","author":"S Kojima","year":"2003","unstructured":"Kojima S, Watanabe N, Numata M, et al. Increase in the prevalence of fatty liver in Japan over the past 12\u00a0years: analysis of clinical background. J Gastroenterol. 2003;38:954\u201361.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1372_CR41","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","volume":"53","author":"ZM Younossi","year":"2011","unstructured":"Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011;53(6):1874\u201382.","journal-title":"Hepatology"},{"key":"1372_CR42","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver diseases: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413\u20139.","journal-title":"Gastroenterology"},{"key":"1372_CR43","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"1372_CR44","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467\u201374.","journal-title":"Am J Gastroenterol"},{"key":"1372_CR45","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholicfatty liver disease. Nat Genet. 2008;40:1461\u20135.","journal-title":"Nat Genet"},{"key":"1372_CR46","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/hep.26440","volume":"58","author":"ND Palmer","year":"2013","unstructured":"Palmer ND, Musani SK, Yerges-Armstrong LM, et al. Characterization of European ancestry nonalcoholic fatty liver disease associated variants in individuals of African and Hispanic descent. Hepatology. 2013;58:966\u201375.","journal-title":"Hepatology"},{"key":"1372_CR47","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cgh.2013.02.011","volume":"11","author":"R Hernaez","year":"2013","unstructured":"Hernaez R, McLean J, Lazo M, et al. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2013;11:1183\u201390.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1372_CR48","doi-asserted-by":"crossref","first-page":"e108381","DOI":"10.1371\/journal.pone.0108381","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Cai W, Song J, et al. Association between the PNPLA3 I148M polymorphism and non-alcoholic fatty liver disease in the Uygur and Han ethnic groups of northwestern China. PLoS One. 2014;9:e108381.","journal-title":"PLoS One"},{"key":"1372_CR49","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s10620-014-3279-z","volume":"59","author":"SS Lee","year":"2014","unstructured":"Lee SS, Byoun YS, Jeong SH, et al. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea. Dig Dis Sci. 2014;59:2967\u201374.","journal-title":"Dig Dis Sci"},{"issue":"13","key":"1372_CR50","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.111.029173","volume":"124","author":"S Cresci","year":"2011","unstructured":"Cresci S, Wu J, Province MA, BARI 2D Study Group, et al. Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial. Circulation. 2011;124(13):1426\u201334.","journal-title":"Circulation"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-017-1372-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,25]],"date-time":"2018-02-25T21:35:21Z","timestamp":1519594521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-017-1372-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,25]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1007\/s00535-017-1372-8","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,25]]}}}